Douglas A. Dyer

Chief Executive Officer at Grace 3, Inc.

Health Technology

Finance

Profile

Douglas A.
Dyer is currently the President, Chief Executive & Financial Officer at Grace 3, Inc. He was previously the President & Director at Q Therapeutics, Inc. in 2011.

Douglas A. Dyer active positions

Companies	Position	Start
Grace 3, Inc. Grace 3, Inc. Financial ConglomeratesFinance Grace 3, Inc. operates as a blank check company. It is a development stage company and serves as a vehicle to effect a merger, exchange of capital stock, and asset acquisition. The company was founded on October 27, 2005 and is headquartered in Red Bank, NJ.	Chief Executive Officer	22/09/2009

All active positions of Douglas A. Dyer

Former positions of Douglas A. Dyer

Companies	Position	End
Q Therapeutics, Inc. Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman on March 28, 2002 and is headquartered in Salt Lake City, UT.	Director of Finance/CFO	03/07/2011

See the detail of Douglas A. Dyer's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies